Related News
Stocks fall most in 2 weeks on bribery probe
Online Edition
SHANGHAI stocks fell the most in two weeks as drug makers retreated amid a national bribery probe.
The key Shanghai Composite Index shed 0.87 percent, the biggest daily loss since July 29, to settle at 2,081.88 points. Daily turnover was 84.7 billion yuan (US$13.9 billion).
The State Administration for Industry and Commerce, a regulator in charge of market supervision, today launched a three-month investigation targeting bribery, fraud and other unfair competition behaviors in the pharmaceutical and other industries.
The nationwide probe came after the corruption scandal of multinational pharmaceutical giant GSK (China) Investment Co Ltd, accused of making millions of dollars in bribes to doctors and others.
“The investigation campaign may affect some pharmaceutical firms’ marketing activities and impact their earnings in the second half of the year,” said Niu Chunbao, an independent analyst.
However, Shi Ming, analyst with Shenyin & Wanguo Securities, said the impact on the pharmaceutical sector would be short-term because the demand is rigid and is mainly driven by an aging population, increasing urbanization and morbidity rates of chronic diseases.
Tianjin Zhongxin Pharmaceutical Group dropped 7.2 percent to 13.30 yuan. Jiangsu Kanion Pharmaceutical Co slumped 6.3 percent to 27.58 yuan. Jiangsu Hengrui Medicine Co lost 5.9 percent to 32.76 yuan.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
